First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 162.35 USD -2.95%
Updated: Apr 26, 2024

Abbvie Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbvie Inc
Total Equity Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Total Equity
$10.4B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
9%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$22.8B
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Equity
$6.2B
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Moderna Inc
NASDAQ:MRNA
Total Equity
$13.9B
CAGR 3-Years
76%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$17.6B
CAGR 3-Years
26%
CAGR 5-Years
32%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$26B
CAGR 3-Years
33%
CAGR 5-Years
24%
CAGR 10-Years
30%

See Also

What is Abbvie Inc's Total Equity?
Total Equity
10.4B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Equity amounts to 10.4B USD.

What is Abbvie Inc's Total Equity growth rate?
Total Equity CAGR 10Y
9%

Over the last year, the Total Equity growth was -40%. The average annual Total Equity growth rates for Abbvie Inc have been -7% over the past three years , and 9% over the past ten years .